We further confirmed that high circulating testosterone and low SHBG levels were associated with an increased risk of breast cancer in our study, likely due to aromatase activity in fat tissues for testosterone (de Jong et al. 2001) and the binding effect of SHBG with estrogen (Arthur et al. 2021; Missmer et al. 2004). Here, CYP19A1 is linked to breast carcinoma.